Timothy Edwin Kelly Praxis Precision Medicines, Inc. (PRAX) insider trading activity

Timothy Edwin Kelly is Chief Financial Officer of Praxis Precision Medicines, Inc.. Currently has a direct ownership of 31,046 shares of PRAX, which is worth approximately $5.94 Million. The most recent transaction as insider was on Jan 12, 2026, when has been sold 943 shares (Common Stock) at a price of $275.74 per share, resulting in proceeds of $260,022. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31K

27.87% 3M change

29.2% 12M change

Total Value Held $5.94 Million

Timothy Edwin Kelly Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 12 2026	SELL Payment of exercise price or tax liability	$260,022 $275.74 p/Share	943 Reduced 2.95%	31,046 Common Stock
Jan 10 2026	SELL Payment of exercise price or tax liability	$385,080 $288.45 p/Share	1,335 Reduced 4.01%	31,989 Common Stock
Jan 08 2026	BUY Grant, award, or other acquisition	-	8,800 Added 20.89%	33,324 Common Stock
Jan 07 2026	SELL Payment of exercise price or tax liability	$40,675 $292.63 p/Share	139 Reduced 0.56%	24,524 Common Stock
Nov 14 2025	BUY Grant, award, or other acquisition	$12,142 $31.62 p/Share	384 Added 1.53%	24,663 Common Stock
May 14 2025	BUY Grant, award, or other acquisition	$7,853 $31.54 p/Share	249 Added 1.02%	24,279 Common Stock
Jan 12 2025	SELL Payment of exercise price or tax liability	$42,689 $63.15 p/Share	676 Reduced 2.74%	24,030 Common Stock

Jan 10 2025	BUY Grant, award, or other acquisition	-	12,500 Added 33.6%	24,706 Common Stock
Jan 07 2025	SELL Payment of exercise price or tax liability	$10,775 $77.52 p/Share	139 Reduced 1.13%	12,206 Common Stock
Nov 14 2024	BUY Grant, award, or other acquisition	$7,667 $37.4 p/Share	205 Added 1.63%	12,345 Common Stock
Jul 29 2024	BUY Grant, award, or other acquisition	-	7,800 Added 39.12%	12,140 Common Stock
May 14 2024	BUY Grant, award, or other acquisition	$7,496 $12.37 p/Share	606 Added 12.25%	4,340 Common Stock
Jan 07 2024	SELL Payment of exercise price or tax liability	$3,501 $25.19 p/Share	139 Reduced 3.59%	3,734 Common Stock
May 12 2023	BUY Grant, award, or other acquisition	$10,281 $0.88 p/Share	11,683 Added 16.74%	58,099 Common Stock
Mar 24 2023	SELL Open market or private purchase	$6,960 $0.87 p/Share	8,000 Reduced 14.7%	46,416 Common Stock
Jan 07 2023	SELL Payment of exercise price or tax liability	$5,239 $2.52 p/Share	2,079 Reduced 5.13%	38,416 Common Stock
Nov 14 2022	BUY Grant, award, or other acquisition	$9 $1.81 p/Share	5 Added 0.01%	40,495 Common Stock
Jun 09 2022	BUY Open market or private purchase	$17,600 $1.76 p/Share	10,000 Added 19.81%	40,490 Common Stock
May 13 2022	BUY Grant, award, or other acquisition	$22,748 $8.8 p/Share	2,585 Added 7.82%	30,490 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	24,000 Added 46.24%	27,905 Common Stock
Aug 31 2021	BUY Open market or private purchase	$76,069 $19.48 p/Share	3,905 Added 50.0%	3,905 Common Stock

TEK

Timothy Edwin Kelly

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRAX shares.

Notify only if

Value

Insider Trading

Get notified when an Praxis Precision Medicines, Inc. insider buys or sells PRAX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Praxis Precision Medicines, Inc.

Track Activities on PRAX

Account